Proscia’s $46M Series C propels AI-driven pathology into the mainstream

Proscia raises $9 million in an extension of its Series C funding round, bringing the total round to $46 million. The funding will be used to accelerate Proscia’s commercial growth and further develop its AI-powered applications for life sciences and diagnostic laboratories. With FDA clearance, Proscia can now bring its digital pathology solutions to diagnostic labs.